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Abstract 
Objectives: Greater understanding of changes in the degree of frailty is important for clarifying the natural history of 
frailty and may help clinical decision-making regarding preventive interventions. The objectives of this study were to 
explore natural frailty transition rates at 1-year follow-up and to identify the main determinants of such transitions. 
Study design: Prospective longitudinal study covering a representative sample of community-dwelling older adults 
aged ≥65 years (n = 749) at baseline, and transition information at 1-year follow-up (n = 537). 
Mean outcome measures: The assessment of frailty status was based on phenotypic criteria (unintentional weight 
loss, weakness, exhaustion, slow walking speed, low physical activity). Frailty transitions (progressed, regressed, no 
change, or death) and associated factors were assessed. 
Results: Most participants remained unchanged from their baseline status (57.1% non-frail, 83.4% pre-frail, 66.7% 
frail). Regarding frailty transitions, 42.9% of non-frail older adults at baseline had progressed to a pre-frail status by 
the 1-year follow-up, and 7.9% of pre-frail older adults had become frail. Importantly, 33.3% of frail older adults 
regressed to a pre-frail status and 8.7% of pre-frail adults had regressed to a non-frail status. Non-frail females tended 
to progress to pre-frailty significantly more than males (p = 0.006), and mortality was higher among participants 
classified as frail at baseline (10.7%). Logistic regression showed that the main determinants of worsening frailty 
were hearing impairment (OR 3.180; 95% CI 1.078–9.384), congestive heart failure (OR 10.864; 95% CI 1.379–
85.614), and polypharmacy (OR 2.572, 95% CI 1.096–6.037). 
Conclusion: Our results confirm the dynamic of frailty and the bidirectional nature of frailty transitions, and indicate 
the need for preventing and treating these conditions in later life in order to minimize the burden of frailty. 
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Physical frailty has been described along a continuum of severity (fitness-frailty spectrum) with three 
stages: non-frailty or robustness, pre-frailty (precursor or latent state) and frailty, and it has been 
associated with adverse health outcomes such as incident falls and fractures, hospitalization, disability, 
dependence and premature death [[1], [2], [3]]. Pre-frail state identifies a subset at high risk of 
progressing to clinically identifiable frail state [2]. Recent literature exploring the natural course of frailty 
in older adults suggests that it is a gradual dynamic process, characterized by frequent transitions between 
frailty states in both directions (worsening or improvement) over time [[4], [5], [6], [7], [8], [9], [10]]. It 
has been shown that transitions are more common between adjacent states (one-step transitions) and from 
states of lesser frailty to states of greater frailty [6,8,[10], [11], [12]], and they appear to be independent of 
progression in cognitive status in earliest stages of cognitive impairment [13]. Recent studies have shown 
that frailty transitions could be modulated by several health and social-related factors [14]. Although 
these findings suggest that frailty is potentially reversible, pharmacological and nonpharmacological 
interventions aimed at preventing and reversing the frailty syndrome or its clinical consequences remain 
elusive [15,16]. In general, it has been suggested that multi-domain (physical and nutritional) 
interventions may delay or even reverse physical frailty [[17], [18], [19], [20], [21], [22], [23]]. Therefore, 
the developing and implementation of specific interventions and effective health-care policies aimed at 
preventing or reducing the level of frailty and postponing its adverse health consequences in old age is 
one of the most important public health challenges. 
 
An important subset of Galician (Northwest of Spain) community-dwelling older adults has been 
shown to be pre-frail and at high risk of progressing to frailty [24]. Evidence about the natural history of 
frailty as a modifiable, bidirectional, and dynamic process is scarce, particularly in the reversion of the 
frailty status. Further understanding of the processes underlying transitions between frailty states (factors 
that positively or negatively contribute to changing the frailty state) is important for clarifying the natural 
history of frailty and may help clinical decision-making related to preventive interventions. The adverse 
health outcomes related to frailty contribute to an increased demand for medical and social care and are 
associated with increased economic costs. For these reasons, it is important that clinicians know the 
frailty process and the main determinants of transitions among its levels, so that effective preventive and 
rehabilitative actions can be taken as early as possible. Since changes in frailty states are of considerable 
clinical and public health interest, the aim of the present study was to explore the natural transition rates 
between states of frailty over a 1-year period and identify the determinants or precipitants of such 
transitions over time in a community-dwelling cohort of older adults. 
2. Methods 
2.1. Study population 
This study was drawn from a sample population of 537 community-dwelling older people aged 65 and 
over who participated in the Effectiveness of the Comprehensive Gerontological Assessment and 
longitudinal follow-up in the healthy aging promotion (VERISAÚDE) project Considering the reference 
population of 632,381 individuals, which represented the absolute number of older adults aged 65 years 
or older from Galicia according to the municipal register of the 2011 National Health Survey, a sample of 
749 older individuals was defined. To ensure a representative sample, the distribution of the sample by 
age and sex was similar to that of the entire Galician older population. The level of confidence was 95%, 
accuracy ±4.0% and estimation of data losses 20.0%. The VERISAÚDE study included a first 
comprehensive gerontological assessment (CGA) with frailty state classified according to the Fried 
phenotypic criteria [2], and a second CGA one year later. The study protocol has been approved by the 
Ethics Committee of the University of A Coruña (CE 09/2013) and was in conformity with the principles 
embodied in the Declaration of Helsinki. Before the data collection, all participants have been informed 
about the study and signed the corresponding informed consent form. The inclusion criteria for the 
participants were as follows: (a) being ≥65 years of age, and (2) willingness to sign the informed consent 
form. The exclusion criterion for the sample was inability to perform the CGA. The manuscript was 
written according to the STrengthening the Reporting of OBservational Studies in Epidemiology 
(STROBE) statement [25]. 
2.2. Frailty assessment and measurement of frailty transitions 
Fried phenotype was used to objectively diagnose frailty [2]. The 5 frailty criteria were: (a) 
Unintentional weight loss of ≥4.5 kg in previous year, (b) Self-reported exhaustion, identified by two 
questions (items 7 and 20) from the Center for Epidemiological Studies-Depression (CES-D) scale, (c) 
Weakness, defined by handgrip strength in the dominant hand measured with a dynamometer in 
kilograms, adjusted for gender and body mass index, (d) Slow walking speed, assessed by the walking 
time (in seconds) over a distance of 4.57 m, adjusting for gender and height, and (e) Low physical 
activity, measured by the weighted score of kilocalories expended per week, calculated on the basis of the 
Minnesota Leisure Time Activity Questionnaire, based on each participant’s report, and adjusting for 
gender. The cut-points used were those proposed by Fried et al. (2001) [2]. At each assessment, 
participants were classified as non-frail (robust) if they met none of the criteria, pre-frail if they met 1 or 2 
criteria, and frail if they met ≥3 criteria [2]. Frailty transitions (progressed, regressed, no change, or death) 
and associated factors were assessed. 
2.3. Comprehensive gerontological assessment 
The CGA included the assessment of sociodemographic characteristics, sensory impairments, toxic 
habits, self-rated health, polypharmacy, comorbidity, nutritional status, cognitive and affective function, 
and functional status at baseline and 1-year follow-up. 
2.3.1. Socio-demographic characteristics 
Information on date of birth, age, sex, and level of education was self-reported. Educational level has 
been classified into three categories according to years of formal education completed: ≤8 years, 9–17 
years, and ≥18 years. 
2.3.2. Visual impairment 
A Snellen eye chart located at a distance of 2.8 m from participant’s eyes was used for screening for 
visual acuity impairment. Decreased visual acuity was defined as best corrected vision worse than 20/50. 
2.3.3. Hearing impairment 
To determine hearing loss, the whispered-voice test was used [26]. The participants were considered 
to have a normal hearing if they repeat back at least 3 out of a possible total of 6 letters/numbers 
correctly, whispered at a distance of 0.6 m behind the participant’s field of vision. 
2.3.4. Toxic habits 
Tobacco and alcohol consumption was self-reported. The variable smoking status (smoker or non-
smoker) was assessed based on the 30 days’ prevalence of cigarette smoking [27]. The exact number of 
Standard Drink Units (SDU) was calculated using the formula: size of drink in milliliters (Vol) x percent 
by volume of alcohol (%) x density of ethanol at room temperature (0.789 g/ml) / by gram in standard 
drink (10 g in Spain). We defined “alcohol abuse” with an upper level of daily consumption >30 g of pure 
alcohol (3 SDU) per day [28]. 
  
2.3.5. Self-rated health 
Self-rated health was assessed with a single question: In general, would you say your health is 
excellent, good, fair, or poor [29]? 
2.3.6. Medication consumption 
Participants were asked to present their medication history (dispensed medications by their general 
practitioner), and polypharmacy was defined as the concurrent use of five or more different prescribed 
medications [30]. 
2.3.7. Comorbidity 
Comorbidity was measured using Charlson Comorbidity Index (CCI) [31]. All the 19 medical 
conditions assessed were assigned a CCI weight (1, 2, 3 or 6) taking into account their number and 
seriousness, which ranges from 0 to 37 points. For each patient, the CCI-aged adjusted score was 
computed, defining three comorbidity levels: 0–1 (no comorbidity), 2 (low comorbidity), and ≥3 (high 
comorbidity). 
2.3.8. Nutritional status 
The Spanish version (Nestlé Nutrition Institute) of the Mini-Nutritional Assessment-Short Form 
(MNA-SF) [32] was used for nutritional screening. The sum of the MNA-SF score distinguishes between 
patients with: 1) normal nutritional status, 12–14 points; 2) at risk of malnutrition, 8–11 points; and 3) 
malnutrition, 0–7 points. 
2.3.9. Cognitive assessment 
The global cognitive status was assessed using the Spanish version of the Mini-Mental State 
Examination (MMSE) [33]. Scores, ranging from 0 to 30, were adjusted for age and level of education, 
and participants were considered as cognitively impaired if they scored <25. 
2.3.10. Affective assessment 
Depressive symptoms were assessed using the Spanish-validated version of the short-form of the 
Geriatric Depression Scale (GDS-SF) [34], which recommends using a cut-off of ≥5 points to consider 
the existence of probable clinical depression. 
2.3.11. Functional status 
Functional status was measured using Lawton and Brody Index [35] for the instrumental activities of 
daily living. The score ranges from 0 (low function, dependence) to 8 (high function, independence). 
Participants who were unable to perform any one of the activities without the help of another person were 
considered to be dependent. 
2.4. Statistical analysis 
The frequencies of natural transitions between the three frailty states (non-frail, pre-frail, frail) and 
death were calculated for those participants who completed the follow-up or died. Thus, worsening 
transitions (from non-frail to pre-frail states and from pre-frail to frail states) and improvement transitions 
(from frail to pre-frail states and from pre-frail to non-frail states) at 1-year follow-up were considered as 
primary outcomes. Participant characteristics were compared across transitions in frailty status using 
student t-tests for continuous variables, and chi-square tests for categorical variables. For multiresponse 
variables, column proportions were compared using custom tables (z test). Cohen’s d and h values were 
reported as indicators of effect size for comparing the mean and proportion values respectively, using the 
benchmarks for “small” (0.2), “medium” (0.5) and “large” (0.8) in both cases [36]. 
  
Frailty transition analyses were performed using a forward stepwise multivariate logistic regression 
method. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for each covariate included 
in the model. A p-value of <0.05 was taken to define statistical significance. The data analyses were 
performed using the software package IBM SPSS Statistics v.24.0 (IBM Corp, Armonk, NY, USA). 
3. Results 
Among the 749 older adults evaluated at baseline, 537 (71.7%) were re-evaluated one year later, and 
212 (28.3%) were lost to follow-up. Drop-out rates as a function of frailty level are shown in Fig. 1. An 
independent t-test revealed that participants who dropped out (n = 212) were slightly older than those who 
participated in the follow-up assessment (n = 537) (76.6 ± 7.5 vs 75.4 ± 7.0 years respectively; p = 0.035). 




Fig. 1. Drop-out Rates as a Function of Frailty Level. 
  






   
Age (years) 75.8 ± 7.2 76.3 ± 7.0 
Gender 
  
 Females 454 (60.6%) 331 (61.6%) 
 Males 295 (39.4%) 206 (38.4%) 
Education 
  
 ≤8 years 451 (60.2%) 323 (60.1%) 
 9-17 years 179 (23.9%) 126 (23.5%) 
 ≥18 years 119 (15.9%) 88 (16.4%) 
Sensory Impairments 
  
 Visual 63 (8.6%) 64 (11.9%) 
 Hearing 209 (27.9%) 182 (33.9%) 
Toxic Habits 
  
 Tobacco consumption 22 (2.9%) 11 (2.1%) 
 Alcohol abuse 83 (11.1%) 71 (13.2%) 
Self-Rated Health, 
  
 Excellent 165 (22.1%) 84 (15.6%) 
 Good 420 (56.1%) 318 (59.2) 
 Fair 142 (19.0%) 124 (23.1%) 
 Poor 21 (2.8%) 11 (2.0%) 
Number of Medications 4.8 ± 3.3 4.8 ± 3.2 
Polypharmacy, ≥5 Medications per day 360 ± 48.1 260 ± 48.4 
Comorbidity 
  
 No comorbidity 580 (77.4%) 416 (77.5%) 
 Low comorbidity 109 (14.6%) 72 (13.4%) 
 High comorbidity 60 (8.0%) 49 (9.1%) 
Nutritional Status, MNA-SF 
  
 Normal 642 (85.7%) 472 (88.1%) 
 Malnutrition risk 101 (13.5%) 62 (11.6%) 
 Malnourished 6 (0.4%) 2 (0.4%) 
Cognitive Impairment 
  
 MMSE <25 49 (6.5%) 34 (6.3%) 
 MMSE score 28.3 ± 0.8 28.4 ± 2.1 
Depressive Symptoms 
  
 GDS-SF ≥5 61 (8.1%) 47 (8.8%) 
 GDS-SF score 1.5 ± 2.1 1.6 ± 2.1 
IADL Dependence 93 (12.4%) 48 (8.9%) 
   
 
Values are presented as means ± standard deviation for continuous variables or as frequencies (percentages) for categorical 
variables. MNA-SF: Mini-Nutritional Assessment-Short Form (ranges 0–14 points; 12–14 points indicate normal nutritional status, 
8–11 points indicate risk of malnutrition, and 0–7 points indicate malnutrition). MMSE: Mini-Mental State Examination (ranges 0–
30 points; <25 points indicate cognitive impairment), GDS-SF: Geriatric Depression Scale-Short Form (ranges 0–15 points; ≥5 
points indicate probable clinical depression). IADL: Instrumental Activities of Daily Living (the score ranges from 0 (low function, 
dependence) to 8 (high function, independence)). 
 
  
3.1. Frailty transitions’ rates 
At baseline, 183 (24.4%) of the participants were non-frail, 538 (71.8%) were pre-frail, and 28 (3.7%) 
were frail. At 1-year follow-up, 113 (21.0%) were non-frail, 382 (71.1%) were pre-frail, and 42 (7.8%) 
were frail. 
 
Fig. 2 shows changes in frailty status from baseline to 1-year follow-up. During the study period, a 
total of 408 (76.0%) participants retained their baseline frailty state, and 129 (24.0%) made transitions 
between states of frailty (16.7% progressed, and 7.3% regressed). Most participants, mainly pre-frail 
subjects, remained unchanged at their baseline state (57.1% non-frail, 83.4% pre-frail, 66.7% frail). 
Regarding frailty transitions, 42.9% of non-frail older adults at baseline progressed to pre-frailty status, 
and 7.9% of pre-frail older adults became frail at 1-year follow-up. Importantly, 33.3% of frail older 
adults regressed to pre-frailty status and 8.7% of pre-frail older adults regressed to non-frailty status. As 
expected, none frail subject regressed to non-frailty status directly. Frailty transition patterns at 1-year 
follow-up are shown in Table 2. As expected, only transitions between adjacent states of frailty were 
observed. As shown in Fig. 2 and Table 2, direct transitions between states of non-frailty and frailty were 
not observed. Non-frail females tended to progress into pre-frailty more than non-frail males, who 




Fig. 2. Percentage of Frailty Transitions in the VERISAÚDE Population from Baseline to 1-Year Follow-Up. Stability in frailty 
status is represented as grey thick arrows, worsening is shown in black color, regression (improvement) is shown in white, and 
percentages of deaths are represented as black thin arrows. 
  
Table 2. Frailty Transitions at 1-Year Follow-Up. 
Frailty Transitions, n (%)  Baseline to 1-Year Follow-Up 
 
 Females (n = 331) Males (n = 206) Total (n = 537) 
     
Non-Frail to:  n = 63 n = 77 n = 140 
Non-Frail  28 (35.0%) 52 (65.0%) 80 (57.1%) 
Pre-Frail  35 (58.3%) 25 (41.7%) 60 (42.9%) 
Frail  0 (0%) 0 (0%) 0 (0%) 
Pre-Frail to:  n = 253 n = 126 n = 379 
Non-Frail  21 (63.6%) 12 (36.4%) 33 (8.7%) 
Pre-Frail  208 (65.8%) 108 (34.2%) 316 (83.4%) 
Frail  24 (80.0%) 6 (20.0%) 30 (7.9%) 
Frail to:  n = 15 n = 3 n = 18 
Non-Frail  0 (0%) 0 (0%) 0 (0%) 
Pre-Frail  4 (66.7%) 2 (33.3%) 6 (33.3%) 
Frail  11 (91.7%) 1 (8.3%) 12 (66.7%) 
     
 
The prevalence of each clinical condition evaluated by the Charlson Comorbidity Index in the 
worsening and improvement groups was calculated, showing that just the prevalence of congestive heart 
failure was significantly different between the groups (24.4% in worsening versus 2.6% in improvement 
groups, p = 0.003, h = .676, medium effect size). 
 
A forward stepwise multivariate logistic regression analysis was made using frailty transitions as a 
dichotomy dependent variable (worsening versus improvement). Age, hearing impairment, congestive 
heart failure, number of medications and polypharmacy were included as independent variables, because 
of the significant differences between groups shown by the bivariate analysis (see Table 3, all medium 
effect sizes). Results of the regression model revealed that hearing impairment (OR = 3.180, 95% CI 
1.078–9.384, p = 0.036), congestive heart failure (OR=10.864, 95% CI 1.379–85.614, p = 0.024), and 
polypharmacy (OR=2.572, 95% CI 1.096–6.037, p = 0.030) at baseline represent more chance of 
experience a transition toward a worse frailty state at 1-year follow-up, with the model accurately 
predicting 70.5% of the worsening cases. 
  
Table 3. Determinants of Transitions Between Frailty States. 
 
Frailty Progression (Worsening) 
n = 90 






     
Age (years), mean (SD) 76.1 (7.1) 73.0 (7.1) 0.025* 0.433a 




 Females 59 (65.6) 25 (64.1) 
  
 Males 31 (34.4) 14 (35.9) 
  




 ≤8 years 57 (63.3) 23 (59.0) 
  
 9-17 years 22 (24.5) 9 (23.1) 
  
 ≥18 years 11 (12.2) 7 (17.9) 
  
Sensory Impairments, n (%) 
    
 Visual 11 (12.6) 3 (7.7) 0.414 
 
 Hearing 28 (31.1) 5 (12.8) 0.029* 0.443b 
Toxic Habits, n (%) 
    
 Tobacco consumption 1 (1.1) 2 (5.1) 0.383 
 
 Alcohol abuse 16 (17.8) 4 (10.3) 0.278 
 




 Excellent 22 (24.5) 7 (17.9) 
  
 Good 45 (50.0) 28 (71.8) 
  
 Fair 20 (22.2) 4 (10.3) 
  
 Poor 3 (3.3) 0 (0.0) 
  
Number of Medications, mean (SD) 5.1 (3.3) 3.8 (2.6) 0.039 0.416a 
Polypharmacy, ≥5 Medications per day, 
n (%) 
47 (52.2) 11 (28.2) 0.012* 0.474b 




 No comorbidity 67 (74.4) 34 (87.2) 
  
 Low comorbidity 14 (15.6) 4 (10.3) 
  
 High comorbidity 9 (10.0) 1 (2.5) 
  




 Normal 74 (82.2) 32 (82.1) 
  
 Malnutrition risk 15 (16.7) 7 (17.9) 
  
 Malnourished 1 (1.1) 0 (0.0) 
  
Cognitive Impairment 
    
 MMSE <25, n (%) 5 (5.6) 1 (2.6) 0.459 
 
 MMSE score, mean (SD) 28.7 (1.9) 28.8 (1.5) 0.858 
 
Depressive Symptoms 
    
 GDS-SF ≥5, n (%) 9 (10.0) 2 (5.1) 0.363 
 
 GDS-SF score, mean (SD) 1.6 (2.2) 1.1 (1.5) 0.107 
 
IADL Dependence, n (%) 13 (14.4) 3 (7.7) .285 
 
     
 
SD: Standard Deviation. 
MNA-SF: Mini-Nutritional Assessment-Short Form (ranges 0–14 points; 12–14 points indicate normal nutritional status, 8–11 
points indicate risk of malnutrition, and 0–7 points indicate malnutrition). MMSE: Mini-Mental State Examination (ranges 0–30 
points; <25 points indicate cognitive impairment), GDS-SF: Geriatric Depression Scale-Short Form (ranges 0–15 points; ≥5 points 
indicate probable clinical depression). IADL: Instrumental Activities of Daily Living (the score ranges from 0 (low function, 
dependence) to 8 (high function, independence)). 
* p < .005. 
a Cohen’s d effect size. 
b Cohen’s h effect size. 
 
  
3.2. Mortality rates 
Mortality rate was higher among participants classified as frail at baseline, with no direct transitions 
from non-frailty to death. Specifically, 1.1% of pre-frail (0.3% females, 2.7% males) and 10.7% of frail 
(13.0% females, none male) participants at baseline died at 1-year follow-up. Females who were frail at 
baseline were more likely to die compared to frail males at baseline. 
4. Discussion 
In the present study, the spontaneous course of frailty was explored in a large community-dwelling 
cohort of older adults estimating the transition rates among states over a 1-year period, and the main 
predictors associated with frailty transitions were identified. This is of clinical and public health interest 
since little is known regarding frailty trajectories within short periods, and the risk factors involved in the 
transitions. 
 
According to previous studies [8,10], most participants (76.0%) remained unchanged at their baseline 
state, with pre-frail individuals being more likely to remain stable than non-frail and frail individuals. It is 
important to note that the prevalence of pre-frailty was considerably high in the studied population [24]. 
Almost a quarter of the participants made transitions between states of frailty (16.7% progressed, and 
7.3% regressed), confirming the dynamic and bidirectional nature of frailty syndrome [8]. As expected, 
transitions towards a worse frailty state were more likely than transitions towards a better frailty state. 
 
In previous studies, pre-frail individuals were shown to be more likely to regress or improve than frail 
individuals [6,10]. Importantly, in our study an important proportion of frail individuals (33.3%) 
regressed to the pre-frailty state, suggesting that even frail state may be an optimal target for intervention. 
According to these findings, a significant proportion of participants (9–16%) improved in frailty status in 
previous studies [6,8,37]. Additionally, females were more likely to decline in frailty status than males in 
the present study. In contrast, a better chance of frailty improvement has been previously reported in 
females [9]. 
 
Risk and protective factors associated with frailty have been widely explored in longitudinal studies 
[38]. Socioeconomic, functional or psychological determinants of transitions, or individual 
clinical/medical characteristics associated with progression or regression over time have been also 
explored in community-dwelling older adults [4,6,7,[9], [10], [11],39]. In a recent innovative study, it has 
been shown that factors that determine the worsening or improvement of frailty state differ as a function 
of gender and that more males than females deteriorate into frailty [9]. In contrast to this finding, females 
were more likely to decline in frailty status than males in the present study. 
 
Our results showed that hearing impairment, congestive heart failure, and polypharmacy were 
significantly associated with worsening within a relatively short period. 
 
According to these findings, in a recent 4-year follow-up study, it was shown that self-reported 
hearing impairment was significantly associated with greater risk of becoming frail in pre-frail 
community-dwelling older adults [40]. Hearing impairment, evaluated by the pure-tone-average of 
hearing thresholds, has been also associated with the risk of frailty and with greater odds of falling in 
older adults [41]. Altogether, these results suggest that hearing impairment, a common condition in later 
life associated with comorbidity, disability and poor quality of life [42,43], may accelerate the 
progression of frailty. 
 
Polypharmacy has been also recently associated with a higher incidence of frailty [44,45] and greater 
mortality [10,46] in longitudinal studies. Specifically, the cumulative exposure to sedative and 
anticholinergic medications was associated with greater risk of transitioning from the robust to the pre-
frail state, and each additional medication was associated with greater risk of transitioning from the robust 
state to death in community-dwelling older men aged 70 and older [44].  
Finally, according to our results, the presence of congestive heart failure was associated with lower 
likelihood of improvement in frailty status [9,37]. 
 
The main strengths of this research are the large representative sample of community-dwelling older 
adults assessed, and the study of frailty transitions occurring within a short time interval. It is important to 
highlight that only active older participants in senior centers were assessed in the present study, possibly 
affecting the generalization of the findings. 
 
A limitation of our study is the little information regarding acute events or factors that may have 
contributed to progression in frailty, such as injury or surgery, acute disease and/or psychological stress. 
Some losses occurred in the 1-year follow-up period with a 28.3% drop-out rate. It is also unclear how the 
use of an alternative operationalization of frailty would have influenced the observed transition rates. 
Finally, it is possible that rates of progression to frailty are related to the presence of specific initial 
physical criteria (different patterns of frailty), and this point should be further explored, together with 
frailty transitions at higher time intervals. 
 
To sum up, our results confirm the dynamic and bidirectional nature of frailty and suggest the need of 
preventing and early treating the hearing impairment and cardiovascular diseases, and tightly monitoring 
polypharmacy in later life in order to optimize health outcomes and minimize the public health burden of 
frailty. It is important that clinicians know the natural frailty process and the main determinants of 
changes in frailty status, in order to take early preventive and rehabilitative actions. 
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